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Background: Although a significant proportion of heart transplant (HTx) recipients have reduced left ventricular global longitudinal strain (LVGLS) 
at the early stages after HTx, no previous study has evaluated the associated risk for mortality. We hypothesized that reduced LVGLS shortly after HTx 
is associated with increased one year mortality among HTx recipients.
Methods:  We included 176 consecutive adult primary single organ orthotopic HTx recipients. Echocardiography was performed 13±6 days post 
HTx. Peak systolic myocardial strain by 2-D speckle tracking echocardiography was assessed in 16 LV segments, and averaged to global strain - an 
index of global LV function.
Results:  Assessment of strain was feasible in 167 (95%) patients. During the first year, 16 (10%) patients died 82±72 days after HTx. LVGLS was 
decreased in non-survivors compared to survivors (p<0.01).
Only 4 (3 %) patients out of 144 with LVGLS better than -10% (-14.3±2.5 %) died the first year after HTx. In contrast, 11 (48 %) patients out of 23 
with LVGLS worse than -10% (-7.8±1.8 %) died during the first year (p<0.05). Importantly, LVGLS was the only significant non-invasiv predictor of 1 
year mortality in a Multivariate Cox regression analysis with HR 1.4 (95% CI 1.0-2.0) per 1 % decrease in strain (Table).
Conclusion: Markedly reduced LV function by GLS is related to poor prognosis in HTx recipients. Early assessment of LVGLS might therefore be a 
predictor of 1 year mortality in these patients.
Univariate and Multivariate Cox Regression Analyses for Survival at 1 Year After HTx (n=176)
Univariate Cox Regression Multivariate Cox Regression
HR 95% CI p HR 95% CI p
Age (years) 1.08 1.00-1.15 0.044 1.02 0.93-1.11 0.71
Mean Arterial Pressure (mmHg) 0.94 0.91-0.97 <0.001 0.99 0.94-1.05 0.83
Donor Age (years) 1.06 1.10-1.11 0.012 1.00 0.95-1.06 1.00
Mean Pulmonary Artery Pressure (mmHg) 1.13 1.05-1.22 0.001 1.05 0.95-1.16 0.35
Cardiac Index (L/min/m2) 0.24 0.09-0.65 0.005 0.56 0.10-3.30 0.52
Pulmonal Vascular Resistance (WU) 4.60 2.65-7.86 <0.001 2.90 1.30-6.70 0.01
Left Ventricular Ejection Fraction (%) 0.88 0.83-0.93 <0.001 0.96 0.84-1.10 0.50
Left Ventricular Global Longitudinal Strain (%) 1.67 1.40-2.01 <0.001 1.43 1.04-1.95 0.03
